# Primary Intrarenal Neuroblastoma in a Four-Month-Old Infant: A Rare Diagnostic Challenge Mimicking Wilms Tumor

**Authors:** Munir Ahmad, Mohammed Alblooshi, Abdalla Aboelkheir, Masih Abdul Kader

PMC · DOI: 10.7759/cureus.81870 · 2025-04-08

## TL;DR

A rare case of primary intrarenal neuroblastoma in a 4-month-old infant was mistaken for Wilms tumor, emphasizing the need for accurate diagnosis and proper treatment.

## Contribution

This case report highlights the diagnostic challenge of primary intrarenal neuroblastoma mimicking Wilms tumor and emphasizes the importance of comprehensive evaluation.

## Key findings

- Primary intrarenal neuroblastoma can clinically and radiologically mimic Wilms tumor.
- Elevated urine catecholamine metabolites and pathological findings confirmed the diagnosis of neuroblastoma.
- Postoperative normalization of metabolite levels and absence of residual disease at ten months indicate successful management.

## Abstract

Primary intrarenal neuroblastoma is an exceedingly rare entity that often mimics Wilms tumor in clinical and radiologic presentation, making prompt differentiation crucial given their divergent treatment pathways and prognostic implications. We present the case of a four-month-old male infant incidentally discovered to have a right-sided abdominal mass. Imaging suggested a renal malignancy, most likely Wilms tumor, but urgent surgical intervention was required due to intralesional bleeding and a precipitous drop in hemoglobin. Elevated urine catecholamine metabolites (homovanillic acid and vanillylmandelic acid) were subsequently detected, but only after the decision for surgery. Intraoperatively, the mass was confirmed to arise from the renal parenchyma rather than the adrenal gland. Pathologic examination revealed sheets of small round blue cells positive for chromogranin, synaptophysin, and cluster of differentiation 56, establishing the diagnosis of neuroblastoma. Four lymph nodes were positive for metastatic involvement, but there was no amplification of the MYCN oncogene. Postoperative urinary catecholamine metabolite levels normalized, and follow-up imaging demonstrated no residual disease at ten months. This case highlights the importance of considering primary intrarenal neuroblastoma in the differential diagnosis of pediatric renal masses and underscores the need for comprehensive imaging and laboratory evaluation to guide appropriate surgical management and postoperative surveillance.

## Linked entities

- **Proteins:** MYCN (MYCN proto-oncogene, bHLH transcription factor)
- **Chemicals:** homovanillic acid (PubChem CID 1738), vanillylmandelic acid (PubChem CID 1245)
- **Diseases:** neuroblastoma (MONDO:0005072), Wilms tumor (MONDO:0006058)

## Full-text entities

- **Genes:** SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613] {aka FGLDS1, MODED, MPAPA, MYCNsORF, MYCNsPEP, N-myc}
- **Diseases:** abdominal mass (MESH:D000007), bleeding (MESH:D006470), Primary Intrarenal Neuroblastoma (MESH:D009447), renal masses (MESH:C536030), Wilms Tumor (MESH:D009396), renal malignancy (MESH:D009369)
- **Chemicals:** vanillylmandelic acid (MESH:D014642), catecholamine (MESH:D002395), homovanillic acid (MESH:D006719)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11976678/full.md

---
Source: https://tomesphere.com/paper/PMC11976678